tm
Seeing Is Believing
tm
Seeing Is Believing
RNAZ is currently covered by 1 analysts with an average price target of $3.03. This is a potential upside of $2.57 (558.7%) from yesterday's end of day stock price of $0.46.
Transcode Therapeutics's activity chart (see below) currently has 0 price targets and 2 ratings on display. The stock rating distribution of RNAZ is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 84 days.
Highest price target for RNAZ is $3, Lowest price target is $3, average price target is $3.03.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 24-Oct-2023. First documented stock forecast 15-Aug-2023.
Currently out of the existing stock ratings of RNAZ, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
3
$2.31 (334.78%)
12
5 months 30 days ago
1/2 (50%)
$2.57 (597.67%)
84
What is RNAZ (Transcode Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RNAZ (Transcode Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RNAZ (Transcode Therapeutics)?
Which analyst is the currently most bullish on RNAZ (Transcode Therapeutics)?
